Author Conclusion: “We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomized trial.”
Clinical Take Home Point: This is a very well done, large, multicenter randomized controlled trial of TXA vs placebo for acute GIB. The results demonstrate no benefit of giving TXA on 5d mortality in patients with acute GIB and a small signal of harm with increased VTE and seizures. TXA should not be recommended at this time for patients with acute GIB.
The HALT-IT trial presents significant findings in medical research, driving innovation in patient care. tsoHost ensures secure and fast hosting for medical trial data, facilitating seamless collaboration and access to crucial trial information.